UK markets closed

Editas Medicine, Inc. (EDIT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.32-0.24 (-4.32%)
At close: 04:00PM EDT
5.35 +0.03 (+0.53%)
After hours: 07:41PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-166,133
-153,219
-220,432
-192,502
-115,976
Depreciation & amortisation
5,929
6,064
6,337
5,053
3,959
Stock-based compensation
22,876
19,798
29,294
43,399
23,156
Change in working capital
-3,121
-1,594
8,176
-21,410
-102,220
Accounts receivable
-3
-5,042
-4,878
5,781
-5,630
Accounts payable
-2,391
-1,492
4,368
-1,139
855
Other working capital
-151,032
-136,897
-181,467
-171,780
-187,005
Other non-cash items
-
1,596
-724
1,657
27,604
Net cash provided by operating activities
-146,282
-132,178
-177,349
-163,803
-179,843
Cash flows from investing activities
Investments in property, plant and equipment
-4,750
-4,719
-4,118
-7,977
-7,162
Purchases of investments
-303,943
-258,517
-315,186
-408,891
-458,404
Sales/maturities of investments
276,950
259,505
433,354
362,402
325,032
Net cash used for investing activities
-31,743
-3,731
114,068
-54,466
-140,522
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
-
117,079
0
249,459
203,726
Net cash used provided by (used for) financing activities
118,231
118,039
1,284
282,106
224,122
Net change in cash
-59,794
-17,870
-61,997
63,837
-96,243
Cash at beginning of period
132,898
145,399
207,396
143,559
239,802
Cash at end of period
73,104
127,529
145,399
207,396
143,559
Free cash flow
Operating cash flow
-146,282
-132,178
-177,349
-163,803
-179,843
Capital expenditure
-4,750
-4,719
-4,118
-7,977
-7,162
Free cash flow
-151,032
-136,897
-181,467
-171,780
-187,005